May T. M. Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
May T. M. Chan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Benítez-Burraco
University of Seville
1 shared publication - Catherine M. Green
Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
1 shared publication - Daniela Moralli
Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
1 shared publication - Dianne F. Newbury
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, OX3 0BP, UK
1 shared publication - Emanuela Valeria Volpi
University of Westminster, School of Life Sciences, London, United Kingdom
1 shared publication - Paloma García-Bellido
Faculty of Modern Languages, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 10 June 2015
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 8 (1) , 1-8
Language impairment in a case of a complex chromosomal rearrangement with a breakpoint downstream of FOXP2
We report on a young female, who presents with a severe speech and language disorder and a balanced de novo complex chromosomal rearrangement, likely to have resulted from a chromosome 7 pericentromeric inversion, followed by a chromosome 7 and 11 translocation. Using molecular cytogenetics, we mapped the four breakpoints to 7p21.1-15.3 (chromosome position: 20,954,043-21,001,537, hg19), 7q31 (chromosome position: 114,528,369-114,556,605, hg19), 7q21.3 (chromosome position: 93,884,065-93,933,453, hg19) and 11p12 (chromosome position: 38,601,145-38,621,572, hg19). These regions contain only non-coding transcripts (ENSG00000232790 on 7p21.1 and TCONS_00013886, TCONS_00013887, TCONS_00014353, TCONS_00013888 on 7q21) indicating that no coding sequences are directly disrupted. The breakpoint on 7q31 mapped 200 kb downstream of FOXP2, a well-known language gene. No splice site or non-synonymous coding variants were found in the FOXP2 coding sequence. We were unable to detect any changes in the expression level of FOXP2 in fibroblast cells derived from the proband, although this may be the result of the low expression level of FOXP2 in these cells. We conclude that the phenotype observed in this patient either arises from a subtle change in FOXP2 regulation due to the disruption of a downstream element controlling its expression, or from the direct disruption of non-coding RNAs.
- 10 June 2015
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 8 (1) , 1-8
Open AccessLanguage impairment in a case of a complex chromosomal rearrangement with a breakpoint downstream of FOXP2
We report on a young female, who presents with a severe speech and language disorder and a balanced de novo complex chromosomal rearrangement, likely to have resulted from a chromosome 7 pericentromeric inversion, followed by a chromosome 7 and 11 translocation. Using molecular cytogenetics, we mapped the four breakpoints to 7p21.1-15.3 (chromosome position: 20,954,043-21,001,537, hg19), 7q31 (chromosome position: 114,528,369-114,556,605, hg19), 7q21.3 (chromosome position: 93,884,065-93,933,453, hg19) and 11p12 (chromosome position: 38,601,145-38,621,572, hg19). These regions contain only non-coding transcripts (ENSG00000232790 on 7p21.1 and TCONS_00013886, TCONS_00013887, TCONS_00014353, TCONS_00013888 on 7q21) indicating that no coding sequences are directly disrupted. The breakpoint on 7q31 mapped 200 kb downstream of FOXP2, a well-known language gene. No splice site or non-synonymous coding variants were found in the FOXP2 coding sequence. We were unable to detect any changes in the expression level of FOXP2 in fibroblast cells derived from the proband, although this may be the result of the low expression level of FOXP2 in these cells. We conclude that the phenotype observed in this patient either arises from a subtle change in FOXP2 regulation due to the disruption of a downstream element controlling its expression, or from the direct disruption of non-coding RNAs.